Cetuximab in refractory squamous cell carcinoma of the anal canal
Rogers, J.E.; Eng, C.
Journal of Gastrointestinal Cancer 45(Suppl 1): 198-200
2014
ISSN/ISBN: 1941-6636 PMID: 24908401 DOI: 10.1007/s12029-014-9626-7
Accession: 052000370
PDF emailed within 0-6 h: $19.90
Related References
Rogers, J.E.; Silva, N.N.; Eng, C. 2015: Cetuximab in combination with cisplatin and 5-Fluorouracil induces dramatic response in metastatic refractory squamous cell carcinoma of the anal canal Journal of Gastrointestinal Oncology 6(5): E82-E85Phan, L.K.; Hoff, P.M. 2007: Evidence of clinical activity for cetuximab combined with irinotecan in a patient with refractory anal canal squamous-cell carcinoma: report of a case Diseases of the Colon and Rectum 50(3): 395-398
Lerner, J.; Michel, M.; Dasanu, C.A. 2020: Relapsed refractory metastatic squamous cell cancer of anal canal in a patient with retroviral infection responding to cetuximab Journal of Oncology Pharmacy Practice: Official Publication of the International Society of Oncology Pharmacy Practitioners 26(4): 1025-1028
De Dosso, S.; Martin, V.; Zanellato, E.; Frattini, M.; Saletti, P. 2010: Molecular characterization and response to cetuximab in a patient with refractory squamous cell anal carcinoma Tumori 96(4): 627-628
Kin, C. 2018: So now my Patient Has Squamous Cell Cancer: Diagnosis, Staging, and Treatment of Squamous Cell Carcinoma of the Anal Canal and Anal Margin Clinics in Colon and Rectal Surgery 31(6): 353-360
De Mestier, P.; Khiari, S.; Vilotte, J. 1989: Sténose œsophagienne par médiastinite carcinomateuse secondaire à un carcinome épidermoïde du canal anal - Anal canal squamous cell carcinoma: esophageal stenosis due to mediastinal carcinomatosis la Semaine des Hopitaux de Paris 65(27): 1705-1707
Poggio, J.L. 2011: Premalignant lesions of the anal canal and squamous cell carcinoma of the anal canal Clinics in Colon and Rectal Surgery 24(3): 177-192
Berry-Lawhorn, J.M.; Palefsky, J.M. 2017: Progression of anal high-grade squamous intraepithelial lesions to anal squamous cell carcinoma and clinical management of anal superficially invasive squamous cell carcinoma Seminars in Colon and Rectal Surgery 28(2): 91-96
Lefevre, J.H. 2010: Traitement combiné par radiochimiothérapie pour cancer épidermoïde du canal anal - Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal cancer Colon and Rectum 4(2): 129-131
Petrelli, N.; Bhargava, A.; Herrera, L.; Shaw, N. 1990: Squamous cell carcinoma scc antigen for serial serum monitoring of patients with primary squamous cell carcinoma of the anal canal Journal of Cancer Research and Clinical Oncology 116(Suppl Part 2): 852
Williams, M.; Swampillai, A.; Osborne, M.; Mawdsley, S.; Hughes, R.; Harrison, M.; Harvey, R.; Glynne-Jones, R. 2013: Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin Cancer 119(13): 2391-2398
Petrelli, N.; Shaw, N.; Bhargava, A.; Herrera, L.; Sischy, B.; Daufelet, J.; Mittelman, A. 1987: Squamous cell carcinoma antigen scc as a marker in patients with primary squamous cell carcinoma of the anal canal Proceedings of the American Association for Cancer Research 28: 182
Mehta, V.; Khan, U.; Pozzessere, N. 2015: Concurrent HPV Negative Squamous Cell Carcinoma of Anal Canal and Squamous Cell Carcinoma of Head and Neck American Journal of Gastroenterology 110: S181-S182
Petrelli, N.J.; Palmer, M.; Herrera, L.; Bhargava, A. 1992: The utility of squamous cell carcinoma antigen for the follow-up of patients with squamous cell carcinoma of the anal canal Cancer 70(1): 35-39
Chawla, A.K.; Willett, C.G. 2001: Squamous cell carcinoma of the anal canal and anal margin Hematology/Oncology Clinics of North America 15(2): 321-344 Vi
Hardy, K.J.; Hughes, E.S.R.; Cuthbertson, A.M. 1972: Squamous Cell Carcinoma of the Anal Canal and Anal Margin Australian and New Zealand Journal of Surgery 38(4): 301-305
Hardy, K.J.; Hughes, E.S.; Cuthbertson, A.M. 1969: Squamous cell carcinoma of the anal canal and anal margin Australian and New Zealand Journal of Surgery 38(4): 301-305
Oblak, I.; Cesnjevar, M.; Anzic, M.; Hadzic, J.B.; Ermenc, A.S.; Anderluh, F.; Velenik, V.; Jeromen, A.; Korosec, P. 2016: The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin Radiology and Oncology 50(1): 113-120
Oblak, I.; Anderluh, F.; Velenik, V.; But-Hadzic, J.; Secerov-Ermenc, A.; Jeromen, A. 2015: P-152 * Impact of anemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin Annals of Oncology 26(Suppl 4): Iv43-Iv43
Oblak, I.; Cesnjevar, M.; Anzic, M.; Hadzic, J.But.; Ermenc, A.Secerov.; Anderluh, F.; Velenik, V.; Jeromen, A.; Korosec, P. 2016: The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin Radiology and Oncology 50(1): 113-120